TEGRETOL CR 200 carbamazepine 200 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

tegretol cr 200 carbamazepine 200 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - carbamazepine, quantity: 200 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; purified talc; titanium dioxide; magnesium stearate; acrylates copolymer; peg-40 hydrogenated castor oil; hypromellose; colloidal anhydrous silica; carmellose sodium; iron oxide yellow; iron oxide red; purified water; ethylcellulose; sodium lauryl sulfate; cetyl alcohol; hydrogen peroxide; octamethylcyclotetrasiloxane; silica dimethicone silylate; dimeticone 5000; cyclomethicone - 1. epilepsy: complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalisation; generalised tonic-clonic seizures; mixed seizure patterns incorporating the above. tegretol is suitable for monotherapy and combination therapy. tegretol is usually not effective in absence seizures, atonic seizures and myoclonic seizures and should not be used for status epilepticus (see "precautions"). 2. trigeminal neuralgia: for relief of pain in idiopathic trigeminal neuralgia and trigeminal neuralgia due to multiple sclerosis; and in idiopathic glossopharyngeal neuralgia. (tegretol is not a simple analgesic and is not intended for trivial facial pain or headache). 3. mania and bipolar affective disorders: treatment of mania and maintenance treatment of bipolar affective disorders to prevent or attenuate recurrence.

TEGRETOL 200 carbamazepine 200 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

tegretol 200 carbamazepine 200 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - carbamazepine, quantity: 200 mg - tablet, uncoated - excipient ingredients: carmellose sodium; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica - 1. epilepsy: complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalisation; generalised tonic-clonic seizures; mixed seizure patterns incorporating the above. tegretol is suitable for monotherapy and combination therapy. tegretol is usually not effective in absence seizures, atonic seizures and myoclonic seizures and should not be used for status epilepticus (see "precautions"). 2. trigeminal neuralgia: for relief of pain in idiopathic trigeminal neuralgia and trigeminal neuralgia due to multiple sclerosis; and in idiopathic glossopharyngeal neuralgia. (tegretol is not a simple analgesic and is not intended for trivial facial pain or headache). 3. mania and bipolar affective disorders: treatment of mania and maintenance treatment of bipolar affective disorders to prevent or attenuate recurrence.

TERIL carbamazepine 200mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

teril carbamazepine 200mg tablet bottle

medtas pty ltd - carbamazepine, quantity: 200 mg - tablet, uncoated - excipient ingredients: pregelatinised maize starch; colloidal anhydrous silica; purified talc; magnesium stearate; sodium starch glycollate; microcrystalline cellulose - epilepsy: partial seizures with complex or simple symptomatology (with or without loss of consciousness), with or without secondary generalisation. generalised seizures with a tonic-clonic component. mixed seizure patterns incorporating the above. teril is suitable for monotherapy and combination therapy. teril is usually not effective in absence seizures, atonic seizures or myoclonic seizures and should not be used for status epilepticus (see precautions). idiopathic trigeminal neuralgia. for the relief of pain in idiopathic trigeminal neuralgia, trigeminal neuralgia due to multiple sclerosis, and idiopathic glossopharyngeal neuralgia. (carbamazepine is not a simple analgesic and is not intended for trivial facial pain or headache). mania and bipolar affective disorders. treatment of mania and maintenance treatment of bipolar affective disorders to prevent or attenuate recurrence.